Acetone → HCID 46195425, compound
Reaction equation
[NH:1]1[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[C:3]2([C:18]3[C:13](=[CH:14][C:15]4[O:21][CH2:20][CH2:19][C:16]=4[CH:17]=3)[O:12][CH2:11][CH2:10]2)[C:2]1=[O:22].CC(C)=O.Br[CH2:28][C:29]1[O:30][C:31]([C:34]([F:37])([F:36])[F:35])=[CH:32][CH:33]=1.BrCC1CCCCO1>CC(=O)CC>[F:35][C:34]([F:37])([F:36])[C:31]1[O:30][C:29]([CH2:28][N:1]2[C:9]3[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=3)[C:3]3([C:18]4[C:13](=[CH:14][C:15]5[O:21][CH2:20][CH2:19][C:16]=5[CH:17]=4)[O:12][CH2:11][CH2:10]3)[C:2]2=[O:22])=[CH:33][CH:32]=1Participants
Procedure
Following the procedure as described in EXAMPLE 4 and making non-critical variations using 2,3,6,7-tetrahydrospiro[furo[3,2-g]chromene-5,3′-indol]-2′(1′H)-one to replace 5,6-dihydrospiro[benzo[1,2-b:5,4-b′]difuran-3,3′-indol]-2″(1′H)-one, acetone to replace butanone, and 2-(bromomethyl)-5-(trifluoromethyl)furan to replace 2-(bromomethyl)tetrahydro-2H-pyran, 1′-{[5-(trifluoromethyl)furan-2-yl]methyl}-2,3,6,7-tetrahydrospiro[furo[3,2-g]chromene-5,3′-indol]-2′(1′H)-one was obtained (43%) as a colorless solid: 1H NMR (300 MHz, CDCl3) δ7.36-6.93 (m, 4H), 6.76-6.70 (m, 1H), 6.38 (d, J=3.5 Hz, 1H), 6.36 (s, 1H), 6.21 (s, 1H), 4.98 (ABq, 2H), 4.80-4.69 (m, 1H), 4.45 (t, J=8.6 Hz, 2H), 4.36-4.28 (m, 1H), 2.92 (t, J=8.5 Hz, 2H), 2.23-2.16 (m, 2H); 13C NMR (75 MHz, CDCl3) δ179.3, 160.6, 155.5, 152.2, 152.1, 141.8, 141.6, 141.3, 135.2, 128.3, 124.1, 123.5, 123.5, 120.6, 120.4, 117.0, 112.6 (2C), 112.5 (2C), 112.1, 109.1, 108.6, 98.6, 71.8, 62.0, 47.8, 36.7, 32.4, 28.8; MS (ES+) m/z 441.7 (M+1).
Sources & evidence
- ORD record
- ord-55d1975a7ec64195a43dcc4c4e7ab0ca
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08263606B2
Reaction notes
Loading…